RBC Capital Maintains Outperform on Boston Scientific, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an Outperform rating on Boston Scientific (NYSE:BSX) and increased the price target from $78 to $82.
April 25, 2024 | 3:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has maintained an Outperform rating on Boston Scientific and raised the price target from $78 to $82.
The upgrade in the price target by RBC Capital indicates a positive outlook on Boston Scientific's stock, suggesting potential upside. This is based on the analyst's assessment and could influence investor sentiment positively in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100